JP2016505018A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016505018A5 JP2016505018A5 JP2015552834A JP2015552834A JP2016505018A5 JP 2016505018 A5 JP2016505018 A5 JP 2016505018A5 JP 2015552834 A JP2015552834 A JP 2015552834A JP 2015552834 A JP2015552834 A JP 2015552834A JP 2016505018 A5 JP2016505018 A5 JP 2016505018A5
- Authority
- JP
- Japan
- Prior art keywords
- individual
- combination according
- combination
- paclitaxel
- albumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361751820P | 2013-01-11 | 2013-01-11 | |
| US61/751,820 | 2013-01-11 | ||
| US201361752355P | 2013-01-14 | 2013-01-14 | |
| US61/752,355 | 2013-01-14 | ||
| US13/794,480 | 2013-03-11 | ||
| US13/794,480 US9511046B2 (en) | 2013-01-11 | 2013-03-11 | Methods of treating pancreatic cancer |
| PCT/US2014/011145 WO2014110443A1 (en) | 2013-01-11 | 2014-01-10 | Methods of treating pancreatic cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018028611A Division JP6697017B2 (ja) | 2013-01-11 | 2018-02-21 | 膵臓がんの処置方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016505018A JP2016505018A (ja) | 2016-02-18 |
| JP2016505018A5 true JP2016505018A5 (enExample) | 2017-02-16 |
| JP6342918B2 JP6342918B2 (ja) | 2018-06-13 |
Family
ID=51165317
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015552834A Active JP6342918B2 (ja) | 2013-01-11 | 2014-01-10 | 膵臓がんの処置方法 |
| JP2018028611A Active JP6697017B2 (ja) | 2013-01-11 | 2018-02-21 | 膵臓がんの処置方法 |
| JP2019033910A Pending JP2019081790A (ja) | 2013-01-11 | 2019-02-27 | 膵臓がんの処置方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018028611A Active JP6697017B2 (ja) | 2013-01-11 | 2018-02-21 | 膵臓がんの処置方法 |
| JP2019033910A Pending JP2019081790A (ja) | 2013-01-11 | 2019-02-27 | 膵臓がんの処置方法 |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US9511046B2 (enExample) |
| EP (1) | EP2943192B9 (enExample) |
| JP (3) | JP6342918B2 (enExample) |
| KR (1) | KR102205710B1 (enExample) |
| CN (2) | CN109793728A (enExample) |
| AU (1) | AU2013203699B2 (enExample) |
| BR (1) | BR112015016681A8 (enExample) |
| CA (1) | CA2897589C (enExample) |
| CY (1) | CY1124273T1 (enExample) |
| DK (1) | DK2943192T3 (enExample) |
| ES (1) | ES2878145T3 (enExample) |
| HK (1) | HK1216853A1 (enExample) |
| HR (1) | HRP20211062T1 (enExample) |
| HU (1) | HUE056612T2 (enExample) |
| IL (2) | IL239739A0 (enExample) |
| LT (1) | LT2943192T (enExample) |
| MX (1) | MX382017B (enExample) |
| NZ (2) | NZ630230A (enExample) |
| PL (1) | PL2943192T3 (enExample) |
| PT (1) | PT2943192T (enExample) |
| RS (1) | RS62076B1 (enExample) |
| SI (1) | SI2943192T1 (enExample) |
| SM (1) | SMT202100377T1 (enExample) |
| WO (1) | WO2014110443A1 (enExample) |
| ZA (1) | ZA201504877B (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1585548T1 (sl) | 2002-12-09 | 2018-11-30 | Abraxis Bioscience, Llc | Sestave in metode odmerjanja farmakoloških sredstev |
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| KR20190062506A (ko) | 2005-02-18 | 2019-06-05 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 조합 및 투여 방식, 및 조합 요법 |
| RU2433818C2 (ru) | 2005-08-31 | 2011-11-20 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Композиции, включающие слаборастворимые в воде фармацевтические вещества и противомикробные вещества |
| CN101605535A (zh) | 2006-12-14 | 2009-12-16 | 阿布拉科斯生物科学有限公司 | 用包含紫杉烷的纳米颗粒基于激素受体状态治疗乳腺癌 |
| WO2008150532A1 (en) * | 2007-06-01 | 2008-12-11 | Abraxis Bioscience, Llc | Methods and compositions for treating recurrent cancer |
| LT2419732T (lt) | 2009-04-15 | 2020-03-10 | Abraxis Bioscience, Llc | Prionų neturinčios nanodalelių kompozicijos ir būdai |
| US9370494B2 (en) | 2010-03-26 | 2016-06-21 | Abraxis Bioscience, Llc | Methods for treating hepatocellular carcinoma |
| WO2011123395A1 (en) | 2010-03-29 | 2011-10-06 | Abraxis Bioscience, Llc | Methods of treating cancer |
| EP2552439B1 (en) | 2010-03-29 | 2022-07-20 | Abraxis BioScience, LLC | Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| PH12012502380B1 (en) | 2010-06-04 | 2019-08-23 | Abraxis Bioscience Llc | Methods of treatment of pancreatic cancer |
| EP3056201A1 (en) * | 2010-06-07 | 2016-08-17 | Abraxis BioScience, LLC | Combination therapy methods for treating proliferative diseases |
| EP2701731B1 (en) | 2011-04-28 | 2020-07-29 | Abraxis BioScience, LLC | Intravascular delivery of nanoparticle compositions and uses thereof |
| MX374915B (es) | 2011-12-14 | 2025-03-06 | Abraxis Bioscience Llc | Uso de excipientes polimericos para liofilizacion o congelacion de particulas. |
| US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| EP3698784A1 (en) | 2013-03-12 | 2020-08-26 | Abraxis BioScience, LLC | Methods of treating lung cancer |
| NZ630213A (en) | 2013-03-14 | 2017-05-26 | Abraxis Bioscience Llc | Methods of treating bladder cancer |
| US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
| US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
| WO2016197100A1 (en) | 2015-06-04 | 2016-12-08 | Crititech, Inc. | Nozzle assembly and methods for use |
| MX381140B (es) | 2015-06-29 | 2025-03-12 | Abraxis Bioscience Llc | Métodos para tratar tumores de células epitelioides. |
| WO2017003908A1 (en) * | 2015-06-30 | 2017-01-05 | The Trustees Of Columbia University In The City Of New York | Talc-bound compositions and uses thereof |
| CA3018989A1 (en) | 2016-04-04 | 2017-10-12 | Crititech, Inc. | Methods for solid tumor treatment |
| WO2018169779A1 (en) * | 2017-03-17 | 2018-09-20 | ImClone, LLC | Combination therapy for pancreatic cancer |
| AU2018279634A1 (en) | 2017-06-09 | 2019-10-31 | Crititech, Inc. | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
| US10398646B2 (en) | 2017-06-14 | 2019-09-03 | Crititech, Inc. | Methods for treating lung disorders |
| CN118649239A (zh) | 2017-10-03 | 2024-09-17 | 克里蒂泰克公司 | 局部递送抗肿瘤颗粒与全身递送免疫治疗剂相结合用于治疗癌症 |
| SG11202009145PA (en) | 2018-03-20 | 2020-10-29 | Abraxis Bioscience Llc | Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin |
| GB201908352D0 (en) * | 2019-06-11 | 2019-07-24 | Innovation Ulster Ltd | Sonodynamic therapy |
| JP7703513B2 (ja) * | 2019-08-01 | 2025-07-07 | ニューヨーク・ユニバーシティ | 抗ガレクチン９抗体と化学療法剤の組合せがん治療 |
| AU2020375810A1 (en) | 2019-10-28 | 2022-05-12 | Abraxis Bioscience, Llc | Pharmaceutical compositions of albumin and rapamycin |
| US20230085602A1 (en) * | 2020-02-04 | 2023-03-16 | Swedish Orphan Biovitrum AB (publ ) | Pdac treatment regimen |
| WO2024186320A1 (en) * | 2023-03-09 | 2024-09-12 | Minneamrita Therapeutics Llc | Drug combination for treatment of pancreatic cancer |
| CN117099681B (zh) * | 2023-08-28 | 2024-07-05 | 南京农业大学 | 一种利用紫杉醇加倍玉米单倍体的方法 |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
| US5439686A (en) | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
| US20030068362A1 (en) | 1993-02-22 | 2003-04-10 | American Bioscience, Inc. | Methods and formulations for the delivery of pharmacologically active agents |
| US5997904A (en) | 1993-02-22 | 1999-12-07 | American Bioscience, Inc. | Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof |
| US6528067B1 (en) | 1993-02-22 | 2003-03-04 | American Bioscience, Inc. | Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof |
| US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
| US5362478A (en) | 1993-03-26 | 1994-11-08 | Vivorx Pharmaceuticals, Inc. | Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell |
| US6753006B1 (en) | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
| US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| NZ262679A (en) | 1993-02-22 | 1997-08-22 | Vivorx Pharmaceuticals Inc | Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell |
| US5650156A (en) | 1993-02-22 | 1997-07-22 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of nutriceuticals and compositions useful therefor |
| US6565842B1 (en) | 1995-06-07 | 2003-05-20 | American Bioscience, Inc. | Crosslinkable polypeptide compositions |
| US20070092563A1 (en) | 1996-10-01 | 2007-04-26 | Abraxis Bioscience, Inc. | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| US20030199425A1 (en) | 1997-06-27 | 2003-10-23 | Desai Neil P. | Compositions and methods for treatment of hyperplasia |
| KR100904931B1 (ko) | 1997-06-27 | 2009-06-29 | 아브락시스 바이오사이언스, 엘엘씨 | 나노 입자 및 그의 제조 방법 |
| US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| EP1171117A4 (en) | 1999-04-22 | 2002-08-07 | American Bioscience Inc | LONG-TERM ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE AGENTS |
| WO2000071079A2 (en) | 1999-05-21 | 2000-11-30 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| ITMI20001107A1 (it) | 2000-05-18 | 2001-11-18 | Acs Dobfar Spa | Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel |
| ITMI20020681A1 (it) * | 2002-03-29 | 2003-09-29 | Acs Dobfar Spa | Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina |
| KR20140027554A (ko) | 2002-12-09 | 2014-03-06 | 아브락시스 바이오사이언스, 엘엘씨 | 약리학적 물질의 조성물 및 그 전달방법 |
| SI1585548T1 (sl) | 2002-12-09 | 2018-11-30 | Abraxis Bioscience, Llc | Sestave in metode odmerjanja farmakoloških sredstev |
| AU2012201568B2 (en) | 2005-02-18 | 2014-07-31 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| KR20190062506A (ko) | 2005-02-18 | 2019-06-05 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 조합 및 투여 방식, 및 조합 요법 |
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| US20070166388A1 (en) | 2005-02-18 | 2007-07-19 | Desai Neil P | Combinations and modes of administration of therapeutic agents and combination therapy |
| KR20080000682A (ko) | 2005-04-29 | 2008-01-02 | 코산 바이오사이언시즈, 인코포레이티드 | 17-ａａｇ 또는 17-ａｇ, 또는 이들의 프로드럭을 사용한다발성 골수종의 치료 방법 |
| NZ592132A (en) | 2005-08-31 | 2012-12-21 | Abraxis Bioscience Llc | Composition comprising nanoparticles of docitaxel and a citrate |
| RU2433818C2 (ru) | 2005-08-31 | 2011-11-20 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Композиции, включающие слаборастворимые в воде фармацевтические вещества и противомикробные вещества |
| JP2007297339A (ja) * | 2006-04-29 | 2007-11-15 | Torii Yakuhin Kk | 癌を治療又は検査するための医薬 |
| JP2010502603A (ja) | 2006-08-31 | 2010-01-28 | アブラクシス バイオサイエンス， エルエルシー | 血管形成を阻害し、血管形成関連疾患を処置する方法 |
| CN101605535A (zh) | 2006-12-14 | 2009-12-16 | 阿布拉科斯生物科学有限公司 | 用包含紫杉烷的纳米颗粒基于激素受体状态治疗乳腺癌 |
| PT2481409T (pt) | 2007-03-07 | 2018-10-18 | Abraxis Bioscience Llc | Nanopartícula que compreende rapamicina e albumina como agente anticancerígeno |
| EP3326630A3 (en) | 2007-05-03 | 2018-08-29 | Abraxis BioScience, LLC | Methods and compositions for treating pulmonary hypertension |
| WO2008150532A1 (en) | 2007-06-01 | 2008-12-11 | Abraxis Bioscience, Llc | Methods and compositions for treating recurrent cancer |
| JP2011517683A (ja) | 2008-04-10 | 2011-06-16 | アブラクシス バイオサイエンス， エルエルシー | 疎水性タキサン誘導体の組成物およびその使用 |
| AU2009234127B2 (en) | 2008-04-10 | 2015-04-30 | Abraxis Bioscience, Llc | Compositions of hydrophobic taxane derivatives and uses thereof |
| KR101674097B1 (ko) * | 2008-04-11 | 2016-11-08 | 시애틀 지네틱스, 인크. | 췌장, 난소 및 다른 암의 검출 및 치료 |
| ES2668837T3 (es) | 2008-12-11 | 2018-05-22 | Abraxis Bioscience, Llc | Terapia de combinación que incluye un taxano y un agente terapéutico adicional |
| GB0900555D0 (en) | 2009-01-14 | 2009-02-11 | Topotarget As | New methods |
| KR101739598B1 (ko) | 2009-03-13 | 2017-06-08 | 아브락시스 바이오사이언스, 엘엘씨 | 티오콜키신 유도체와의 조합 요법 |
| EP2416650B1 (en) | 2009-04-10 | 2020-02-26 | Abraxis BioScience, LLC | Nanoparticle formulations and uses therof |
| LT2419732T (lt) | 2009-04-15 | 2020-03-10 | Abraxis Bioscience, Llc | Prionų neturinčios nanodalelių kompozicijos ir būdai |
| US8383358B2 (en) * | 2009-05-28 | 2013-02-26 | Abraxis Bioscience, Llc | Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy |
| ES2577024T3 (es) | 2009-08-25 | 2016-07-12 | Abraxis Bioscience, Llc | Terapia combinada con composiciones de nanopartículas de taxano e inhibidores de Hedgehog |
| JP2011079788A (ja) * | 2009-10-08 | 2011-04-21 | Oita Univ | 膵癌に対する選択的膵動脈制癌剤注入療法と全身化学療法との併用療法、およびそれに使用する膵癌治療薬 |
| KR101754437B1 (ko) * | 2010-01-05 | 2017-07-05 | 바스큘라 바이오제닉스 리미티드 | 특이적 항-혈관형성 아데노바이러스제의 사용방법 |
| US9370494B2 (en) | 2010-03-26 | 2016-06-21 | Abraxis Bioscience, Llc | Methods for treating hepatocellular carcinoma |
| WO2011123395A1 (en) | 2010-03-29 | 2011-10-06 | Abraxis Bioscience, Llc | Methods of treating cancer |
| EP2552439B1 (en) | 2010-03-29 | 2022-07-20 | Abraxis BioScience, LLC | Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| US20130005678A1 (en) | 2010-03-30 | 2013-01-03 | Clavis Pharma Asa | Methods and Compositions for Treating or Ameliorating Cancer Using Gemcitabine-5'-Elaidate |
| RU2621640C2 (ru) | 2010-06-02 | 2017-06-06 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способы лечения рака мочевого пузыря |
| PH12012502380B1 (en) | 2010-06-04 | 2019-08-23 | Abraxis Bioscience Llc | Methods of treatment of pancreatic cancer |
| EP3056201A1 (en) | 2010-06-07 | 2016-08-17 | Abraxis BioScience, LLC | Combination therapy methods for treating proliferative diseases |
| EP2701731B1 (en) | 2011-04-28 | 2020-07-29 | Abraxis BioScience, LLC | Intravascular delivery of nanoparticle compositions and uses thereof |
| MX374915B (es) | 2011-12-14 | 2025-03-06 | Abraxis Bioscience Llc | Uso de excipientes polimericos para liofilizacion o congelacion de particulas. |
| US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US20140186447A1 (en) | 2012-12-28 | 2014-07-03 | Abraxis Bioscience, Llc | Nanoparticle compositions of albumin and paclitaxel |
| US20140199404A1 (en) | 2013-01-11 | 2014-07-17 | Abraxis Bioscience, Llc | Method for treating cancer based on level of a nucleoside transporter |
| US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| US20140199405A1 (en) | 2013-01-11 | 2014-07-17 | Abraxis Bioscience, Llc | Method for treating cancer based on mutation status of k-ras |
| BR112015019064A8 (pt) | 2013-02-11 | 2019-11-12 | Abraxis Bioscience Llc | uso de uma composição compreendendo nanopartículas compreendendo paclitaxel e uma albumina para o tratamento de melanoma e kit |
| EP3698784A1 (en) | 2013-03-12 | 2020-08-26 | Abraxis BioScience, LLC | Methods of treating lung cancer |
| CA2903470A1 (en) | 2013-03-13 | 2014-09-18 | Abraxis Bioscience, Llc | Methods of treatment of pediatric solid tumor |
| NZ630213A (en) | 2013-03-14 | 2017-05-26 | Abraxis Bioscience Llc | Methods of treating bladder cancer |
| US20170202782A1 (en) | 2014-04-06 | 2017-07-20 | Abraxis Bioscience, Llc | Combination therapy comprising nanoparticles of a taxane and albumin with abt-263 in methods for treating cancer |
| WO2016141365A1 (en) | 2015-03-05 | 2016-09-09 | Abraxis Bioscience, Llc | Method for treating cancer based on level of glucocorticoid receptor |
| CA2990703C (en) | 2015-06-29 | 2024-04-30 | Abraxis Bioscience, Llc | Biomarkers for nanoparticle compositions |
| CN107921006A (zh) | 2015-06-29 | 2018-04-17 | 阿布拉科斯生物科学有限公司 | 使用纳米颗粒mtor抑制剂联合疗法治疗实体瘤的方法 |
| MX381140B (es) | 2015-06-29 | 2025-03-12 | Abraxis Bioscience Llc | Métodos para tratar tumores de células epitelioides. |
| US20170181988A1 (en) | 2015-12-23 | 2017-06-29 | Cipla Limited | Methods for the treatment of bladder cancer |
-
2013
- 2013-03-11 US US13/794,480 patent/US9511046B2/en active Active
- 2013-04-11 AU AU2013203699A patent/AU2013203699B2/en active Active
-
2014
- 2014-01-10 SI SI201431853T patent/SI2943192T1/sl unknown
- 2014-01-10 HU HUE14737791A patent/HUE056612T2/hu unknown
- 2014-01-10 CN CN201910067315.0A patent/CN109793728A/zh active Pending
- 2014-01-10 NZ NZ630230A patent/NZ630230A/en unknown
- 2014-01-10 HK HK16104890.5A patent/HK1216853A1/zh unknown
- 2014-01-10 PL PL14737791T patent/PL2943192T3/pl unknown
- 2014-01-10 DK DK14737791.5T patent/DK2943192T3/da active
- 2014-01-10 LT LTEP14737791.5T patent/LT2943192T/lt unknown
- 2014-01-10 NZ NZ734971A patent/NZ734971A/en unknown
- 2014-01-10 KR KR1020157021320A patent/KR102205710B1/ko active Active
- 2014-01-10 HR HRP20211062TT patent/HRP20211062T1/hr unknown
- 2014-01-10 PT PT147377915T patent/PT2943192T/pt unknown
- 2014-01-10 SM SM20210377T patent/SMT202100377T1/it unknown
- 2014-01-10 JP JP2015552834A patent/JP6342918B2/ja active Active
- 2014-01-10 MX MX2015008898A patent/MX382017B/es unknown
- 2014-01-10 WO PCT/US2014/011145 patent/WO2014110443A1/en not_active Ceased
- 2014-01-10 BR BR112015016681A patent/BR112015016681A8/pt not_active Application Discontinuation
- 2014-01-10 CA CA2897589A patent/CA2897589C/en active Active
- 2014-01-10 CN CN201480013217.4A patent/CN105025893A/zh active Pending
- 2014-01-10 RS RS20210823A patent/RS62076B1/sr unknown
- 2014-01-10 EP EP14737791.5A patent/EP2943192B9/en not_active Revoked
- 2014-01-10 ES ES14737791T patent/ES2878145T3/es active Active
-
2015
- 2015-07-01 IL IL239739A patent/IL239739A0/en unknown
- 2015-07-07 ZA ZA2015/04877A patent/ZA201504877B/en unknown
-
2016
- 2016-10-06 US US15/287,613 patent/US9855220B2/en active Active
-
2017
- 2017-11-21 US US15/820,022 patent/US10328031B2/en active Active
-
2018
- 2018-02-21 JP JP2018028611A patent/JP6697017B2/ja active Active
-
2019
- 2019-02-27 JP JP2019033910A patent/JP2019081790A/ja active Pending
-
2020
- 2020-02-26 IL IL272905A patent/IL272905A/en unknown
-
2021
- 2021-06-30 CY CY20211100585T patent/CY1124273T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016505018A5 (enExample) | ||
| JP2016513097A5 (enExample) | ||
| HRP20211062T1 (hr) | Metode liječenja raka gušterače koje uključuju paklitaksel i gemcitabin | |
| MX2015011752A (es) | Metodos para tratar cancer de pulmon. | |
| MX364637B (es) | Platino y nanopartículas que incluyen placlitaxel/albúmina para usarse en el trartamiento de nsclc. | |
| JP2010509331A5 (enExample) | ||
| JP2013523656A5 (enExample) | ||
| HRP20160609T1 (hr) | Postupci liječenja hepatocelularnog karcinoma | |
| HK1217292A1 (zh) | 基於k- ras的突变状态治疗癌症的方法 | |
| MY188911A (en) | Methods of treating bladder cancer | |
| JP2013518815A5 (enExample) | ||
| JP2008274047A5 (enExample) | ||
| WO2015035094A8 (en) | Methods of treatment of cancer by continuous infusion of coenzyme q10 | |
| JP2017527582A5 (enExample) | ||
| Amin et al. | Evaluation of acute and subchronic toxicity of silver nanoparticles in normal and irradiated animals | |
| RU2012107095A (ru) | ИНГИБИРОВАНИЕ МЕТАСТАЗИРОВАНИЯ ОПУХОЛИ ПРИ ПОМОЩИ АНТАГОНИСТОВ Bv8 ИЛИ G-CSF | |
| JP2017511599A5 (enExample) | ||
| JP2018513155A5 (enExample) | ||
| JP2019529520A5 (enExample) | ||
| RU2019105574A (ru) | Противоопухолевый агент, усилитель противоопухолевого действия и противоопухолевый набор | |
| JP2017516827A5 (enExample) | ||
| JP2015146883A5 (enExample) | ||
| WO2015038925A3 (en) | Novel delivery compositions and methods of using same | |
| JP2013522350A5 (enExample) | ||
| JP2016502083A5 (enExample) |